Publications

Concentrations of dehydroepiandrosterone-sulphate (DHEA-S) in people with cystic fibrosis on and off elexacaftor-tezacaftor-ivacaftor

Abid S, Shaffer L, Bayat A, Lee M, Keller A, Jain R 2024 Sep 23 874-877

Prioritizing sexual and reproductive health research and care for people with cystic fibrosis: A 2023 workshop report from the Cystic Fibrosis Foundation Sexual Health, Reproduction, and Gender (SHARING) Research Working Group

Kazmerski TM, Moy C, Aliaj E, Hudson J, Wright B, Poranski M, Sjoberg J, Taylor-Cousar JL, Georgiopoulos AM, Ladores SL, Trimble A, Tangpricha V, Khan FN, Ramasamy R, Leitner DV, West NE, Santos RD, Stransky OM, Wilson A, Keller A, Jain R 2024 Jul 23 639-646

In vivo editing of lung stem cells for durable gene correction in mice

Sun Y, Chatterjee S, Lian X, Traylor Z, Sattiraju SR, Xiao Y, Dilliard SA, Sung YC, Kim M, Lee SM, Moore S, Wang X, Zhang D, Wu S, Basak P, Wang J, Liu J, Mann RJ, LePage DF, Jiang W, Abid S, Hennig M, Martinez A, Wustman BA, Lockhart DJ, Jain R, Conlon RA, Drumm ML, Hodges CA, Siegwart DJ 2024 Jun 384 1196-1202

Factors associated with pubertal growth outcomes in cystic fibrosis: Early Growth and Puberty in CF

Patil R, Magaret AS, Jain R, Taylor-Cousar J, Hughan KS, Kazmerski TM 2024 May 23 538-544

Clinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosis

Kazmerski TM, Stransky OM, Lavage DR, Hughan KS, Jain R, Ladores SL, Stalvey MS, Tangpricha V, Taylor-Cousar JL, West NE, Sawicki GS 2024 May 23 417-423

The impact of switching to race-neutral reference equations on FEV1 percent predicted among people with cystic fibrosis

Rosenfeld M, Cromwell EA, Schechter MS, Ren C, Flume PA, Szczesniak RD, Morgan WJ, Jain R 2024 May 23 443-449

A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancy

Taylor-Cousar JL, Janney R, Middleton PG, Jain R, Nightingale J, West NE, Shteinberg M, Velez D, Kazmerski TM 2024 May 23 412-416

Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

Wang A, Lee MJ, Keller A, Jian S, Lowe K, Finklea JD, Jain R 2024 Jan 23 91-98

The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis

Jain R, Kazmerski TM, Taylor-Cousar JL 2023 Nov 29 595-602

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

Mayer-Hamblett N, Clancy JP, Jain R, Donaldson SH, Fajac I, Goss CH, Polineni D, Ratjen F, Quon BS, Zemanick ET, Bell SC, Davies JC, Jain M, Konstan MW, Kerper NR, LaRosa T, Mall MA, McKone E, Pearson K, Pilewski JM, Quittell L, Rayment JH, Rowe SM, Taylor-Cousar JL, Retsch-Bogart G, Downey DG 2023 Oct 11 932-944

Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis

Peng G, Taylor-Cousar JL, Lee MJ, Keller A, West NE, Kazmerski TM, Goralski JL, Aitken ML, Roe AH, Hadjiliadis D, Uluer A, Flume PA, Mody S, Bray LA, Jain R 2023 Sep 22 796-803

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

Author Collaboration V, Author Collaboration VS, Uluer AZ, MacGregor G, Azevedo P, Indihar V, Keating C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Rubenstein RC, Taylor-Cousar JL, Tullis E, Yonker LM, Chu C, Lam AP, Nair N, Sosnay PR, Tian S, Van Goor F, Viswanathan L, Waltz D, Wang LT, Xi Y, Billings J, Horsley A, Nash EF, Bakker M, van der Meer R, Merkus P, Majoor C, McCoy K, Pancham K, Tolle J, Quick B, Uluer A, DiMango E, Rao A, Reyes S, Klingsberg R, Barreto C, Ortega V, Willey-Courand D, Schwarz C, Sutharsan S, Fischer R, Davies J, Duckers J, Doe S, Heijerman H, Jain R 2023 Jun 11 550-562

Chronic Pancreatitis Associated With a Variant of CFTR Gene Treated With Total Pancreatectomy and Autologous Islet Cell Transplantation

Agarwal S, Lingvay I, Mirfakhraee S, Jain R 2023 May 9 93-96

Menopause in people with cystic fibrosis

Prochownik K, Jain R, Taylor-Cousar JL, Lavage DR, Stransky OM, Thomas HN, Kazmerski TM 2023 Apr 30 401-405

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Author Collaboration SS, Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH, Kloster M, Weaver K, Chapdu C, Xie J, Skalland M, Romasco M, Heltshe S, Simon N, VanDalfsen J, Mead A, Buckingham R, Seidel K, Midamba N, Couture L, Case BZ, Au W, Rockers E, Cooke D, Olander A, Bondick I, Johnson M, VanHousen L, Nicholson B, Parrish M, Roberts D, Head J, Jain R, Sharma P 2023 Apr 11 329-340

Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor

Patel P, Yeley J, Brown C, Wesson M, Lesko BG, Slaven JE, Chmiel JF, Jain R, Sanders DB 2023 Mar 9

Partner perspectives on women's sexual and reproductive healthcare in cystic fibrosis

Ehrenberg S, Stransky OM, Wright CE, Jain R, Kazmerski TM 2023 Mar 22 217-222

Sexual and reproductive health experiences and care of adult women with cystic fibrosis

Kazmerski TM, Stransky OM, Lavage DR, Taylor-Cousar JL, Sawicki GS, Ladores SL, Godfrey EM, Aitken ML, Fields A, Sufian S, Jain M, Barto TL, Billings J, Hadjiliadis D, Jain R 2023 Mar 22 223-233

Clinician attitudes and practices on pregnancy planning and care in cystic fibrosis

Montemayor K, Kazmerski TM, Riekert KA, Psoter KJ, Jain R, Taylor-Cousar JL, Aitken ML, Boyle RL, Patel S, West NE 2023 Mar 22 201-206

The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis

Taylor-Cousar JL, Shteinberg M, Cohen-Cymberknoh M, Jain R 2023 Mar 45 278-289

SEXUAL HEALTH, FERTILITY, AND PREGNANCY IN PEOPLE WITH CYSTIC FIBROSIS

Jain R, Sawyer SM, Cohen-Cymberknoh M 2023 Jan 415-425

Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosis

Abid S, Lee MJ, Rodich B, Hook JS, Moreland JG, Towler D, Maalouf NM, Keller A, Ratti G, Jain R 2023 Jan 22 140-145

Family Planning and Reproductive Health in Cystic Fibrosis

Meiss LN, Jain R, Kazmerski TM 2022 Dec 43 811-820

Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding

Jain R, Wolf A, Molad M, Taylor-Cousar J, Jr CR, Shteinberg M 2022 Nov 21 1074-1076

Cystic Fibrosis: Highly Effective Targeted Therapeutics and the Impact on Sex and Racial Disparities

Montemayor K, Jain R 2022 Nov 106 1001-1012

Changes in Care during the COVID-19 Pandemic for People with Cystic Fibrosis

Sanders DB, Wu R, O'Neil T, Elbert A, Petren K, Jain R, Ren CL 2022 Oct 19 1697-1703

Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening

Ratti GA, Fernandez GS, Schechter MS, Stalvey MS, Ostrenga J, Fink AK, Jain R 2022 Sep 21 784-791

Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry

Szentpetery S, Fernandez GS, Schechter MS, Jain R, Flume PA, Fink AK 2022 Sep 21 777-783

Parenthood impacts short-term health outcomes in people with cystic fibrosis

Kazmerski TM, Jain R, Lee MJ, Taylor-Cousar JL 2022 Jul 21 662-668

Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design

Jain R, Magaret A, Vu PT, Vandalfsen JM, Keller A, Wilson A, Putman MS, Mayer-Hamblett N, Esther CR, Taylor-Cousar JL 2022 Jun 9

Management of pregnancy in cystic fibrosis

Montemayor K, Tullis E, Jain R, Taylor-Cousar JL 2022 Jun 18

Pregnancy in cystic fibrosis: Review of the literature and expert recommendations

Jain R, Kazmerski TM, Zuckerwise LC, West NE, Montemayor K, Aitken ML, Cheng E, Roe AH, Wilson A, Mann C, Ladores S, Sjoberg J, Poranski M, Taylor-Cousar JL 2022 May 21 387-395

Understanding the Intersection between Gender Transition and Health Outcomes in Cystic Fibrosis

Shaffer LR, McCormack E, Sawicki GS, Keller A, Jain R 2022 Mar 19 504-506

Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study

Goss CH, Fajac I, Jain R, Seibold W, Gupta A, Hsu MC, Sutharsan S, Davies JC, Mall MA 2022 Feb 59

Family-building and parenting considerations for people with cystic fibrosis

Kazmerski TM, West NE, Jain R, Uluer A, Georgiopoulos AM, Aitken ML, Taylor-Cousar JL 2022 Feb 57 S75-S88

Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis

West NE, Kazmerski TM, Taylor-Cousar JL, Tangpricha V, Pearson K, Aitken ML, Jain R 2022 Feb 57 S89-S100

Engaging Stakeholders in the Development of a Reproductive Goals Decision AID for Women with Cystic Fibrosis

Stransky OM, Pam M, Ladores SL, Birru Talabi M, Borrero S, Godfrey EM, Roe AH, Sawicki GS, Zuckerwise LC, Mody S, Mentch L, Deal A, O’Leary R, Taylor-Cousar JL, Jain R, Kazmerski TM 2022 Feb 9

A randomized clinical trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment

Author Collaboration SI, Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA 2021 Dec 204 1295-1305

Men's health in the modern era of cystic fibrosis

Khan FN, Tangpricha V, Hughan KS, Jain R, Ladores SL, Taylor-Cousar JL, West NE, Montemayor K, Sawicki GS, Uluer A, Aitken ML, Shnorhavorian M, Bray LA, Kvam C, Stalvey M, Kazmerski TM 2021 Nov 20 e121-e123

Challenges Faced by Women with Cystic Fibrosis

Jain R, Kazmerski TM, Aitken ML, West N, Wilson A, Bozkanat KM, Montemayor K, von Berg K, Sjoberg J, Poranski M, Taylor-Cousar JL 2021 Sep 42 517-530

A prospective study of the effects of sex hormones on lung function and inflammation in women with cystic fibrosis

Holtrop M, Heltshe S, Shabanova V, Keller A, Schumacher L, Fernandez L, Jain R 2021 Jul 18 1158-1166

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Author Collaboration Vs, Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE, Gibson RL, Rowe SM, Lechtzin N, Ahrens RC, McCoy KS, Aitken M, Donaldson SH, McBennett KA, Pilewski JM, Billings J, Milla C, Rubenstein R, Rosenbluth DB, Linnemann R, Powers MR, Fortner C, Frederick CA, Liou TG, Black P, Wang J, Colombo JL, Berdella M, Indihar MV, Brown CD, Anstead M, Bilodeau L, Sicilian L, Tolle JJ, Moffett K, Jain R 2021 Jul 9 733-746

Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies

Bozkanat KM, West NE, Ladores S, Montemayor K, Tupayachi Ortiz MG, Christianson M, Jain R 2021 Jun 9

Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis

Taylor-Cousar JL, Jain R, Kazmerski TM, Aitken ML, West NE, Wilson A, Middleton PG, Nash EF 2021 May 20 395-396

Fertility, pregnancy and lactation considerations for women with cf in the cftr modulator era

Jain R, Taylor-Cousar JL 2021 May 11

Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation

Taylor-Cousar JL, Jain R 2021 May 20 402-406

Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment

Harruff EE, Kil J, Ortiz MG, Dorgan D, Jain R, Poth EA, Fifer RC, Kim YJ, Shoup AG, Flume PA 2021 Mar 20 288-294

In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis

Nolan PJ, Jain R, Cohen L, Finklea JD, Smith TT 2021 Feb 99

Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients

Conrad DJ, Billings J, Teneback C, Koff J, Rosenbluth D, Bailey BA, Jain R 2021 Jan 20 91-96

Gender-affirming hormone therapy in cystic fibrosis – A case of new Pseudomonas infection

Shaffer L, Bozkanat K, Lau M, Sharma P, Sathe M, Lopez X, Jain R 2021 Jan 32

Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development

Jain R, Baines A, Khan U, Wagner BD, Sagel SD 2021 Jan 20 50-56

End-of-Life Care in Cystic Fibrosis: Comparing Provider Practices Based on Lung Transplant Candidacy

Lange AV, Rueschhoff A, Terauchi S, Cohen L, Reisch J, Jain R, Finklea JD 2020 Dec 23 1606-1612

Caring for gender diverse youth with cystic fibrosis

Kidd KM, Sequeira GM, Voss RV, Weiner DJ, Ramsey BW, Jain R, Kazmerski TM 2020 Nov 19 1018-1020

Access to coronavirus disease 2019 clinical trials by english and non-english speakers is needed

Jain MK, Rollins N, Jain R 2020 Oct 71 2298-2299

An innovative phase ii trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor bi 1265162 in adults and adolescents with cystic fibrosis: Balance-cftm 1

Goss CH, Jain R, Seibold W, Picard AC, Hsu MC, Gupta A, Fajac I 2020 Oct 6 1-8

Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry

Godfrey EM, Mody S, Schwartz MR, Heltshe SL, Taylor-Cousar JL, Jain R, Sufian S, Josephy T, Aitken ML 2020 Jun 101 420-426

Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation. Reply

Jain R, Middleton PG, Rowe SM 2020 Feb 382

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Author Collaboration VT, Heijerman HG, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, Ahluwalia N, Xuan F, Zhang Y, Taylor-Cousar JL, McCoy KS, McCoy K, Donaldson S, Walker S, Chmiel J, Rubenstein R, Froh DK, Neuringer I, Jain M, Moffett K, Taylor-Cousar JL, Barnett B, Mueller G, Flume P, Livingston F, Mehdi N, Teneback C, Welter J, Jain R, Kissner D, Patel K, Calimano FJ, Johannes J, Daines C, Keens T, Scher H, Chittivelu S, Reddivalam S, Klingsberg RC, Johnson LG, Verhulst S 2019 Nov 394 1940-1948

Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele

Author Collaboration VS, Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R 2019 Nov 381 1809-1819

AcrAB-TolC Inhibition by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity in Vitro and in Vivo

Sturge CR, Felder-Scott CF, Pifer R, Pybus C, Jain R, Geller BL, Greenberg DE 2019 Aug 5 1446-1455

Impact of high- versus low-risk genotype on sinonasal radiographic disease in cystic fibrosis

Halderman AA, Lee S, London NR, Day A, Jain R, Moore JA, Lin SY 2019 Apr 129 788-793

Disparities in mortality of hispanic patients with cystic fibrosis in the United States a national and regional cohort study

Rho J, Ahn C, Gao A, Sawicki GS, Keller A, Jain R 2018 Oct 198 1055-1063

Female sex and gender in lung/sleep health and disease: Increased understanding of basic biological, pathophysiological, and behavioral mechanisms leading to better health for female patients with lung disease

Han ML, Arteaga-Solis E, Blenis J, Bourjeily G, Clegg DJ, DeMeo D, Duffy J, Gaston B, Heller NM, Hemnes A, Henske EP, Jain R, Lahm T, Lancaster LH, Lee J, Legato MJ, McKee S, Mehra R, Morris A, Prakash YS, Stampfli MR, Gopal-Srivastava R, Laposky AD, Punturieri A, Reineck L, Tigno X, Clayton J 2018 Oct 198 850-858

Diagnosing cystic fibrosis in adults: Better late than never

Jain R 2018 Oct 15 1140-1141

Effects of an antioxidant-enriched multivitamin in cystic fibrosis

Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML 2018 Sep 198 639-647

Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients

Finklea JD, Hollaway R, Lowe K, Lee F, Le J, Jain R 2018 Sep 92 75-77

KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa

Jain R, Beckett VV, Konstan MW, Accurso FJ, Burns JL, Mayer-Hamblett N, Milla C, VanDevanter DR, Chmiel JF 2018 Jul 17 484-491

Antisense Inhibitors Retain Activity in Pulmonary Models of Burkholderia Infection

Daly SM, Sturge CR, Marshall-Batty KR, Felder-Scott CF, Jain R, Geller BL, Greenberg DE 2018 May 4 806-814

Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

Atkin SD, Abid S, Foster M, Bose M, Keller A, Hollaway R, Sader HS, Greenberg DE, Finklea JD, Castanheira M, Jain R 2018 11 1499-1510

Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations

West NE, Beckett VV, Jain R, Sanders DB, Nick JA, Heltshe SL, Dasenbrook EC, VanDevanter DR, Solomon GM, Goss CH, Flume PA 2017 Sep 16 600-606

Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis

VanDevanter DR, Heltshe SL, Spahr J, Beckett VV, Daines CL, Dasenbrook EC, Gibson RL, Jain R, Sanders DB, Goss CH, Flume PA 2017 Sep 16 607-615

17β-Estradiol dysregulates innate immune responses to Pseudomonas aeruginosa respiratory infection and is modulated by estrogen receptor antagonism

Abid S, Xie SK, Bose M, Shaul PW, Terada LS, Brody SL, Thomas PJ, Katzenellenbogen JA, Kim SH, Greenberg DE, Jain R 2017 85

Lung transplantation and gender effects on survival of recipients with cystic fibrosis

Raghavan D, Gao A, Ahn C, Kaza V, Finklea J, Torres F, Jain R 2016 Dec 35 1487-1496

Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial

Heubi JE, Schaeffer D, Ahrens RC, Sollo N, Strausbaugh S, Graff G, Jain R, Witte S, Forssmann K 2016 Sep 176 156-161.e1

Evaluating Outcomes Disparities in the Hispanic Cystic Fibrosis Population: A Need for a National Analysis

Rho J, Ahn C, Gao A, Keller A, Jain R 2016 Sep 150 751-753

Increasing awareness of sex differences in airway diseases

Raghavan D, Jain R 2016 Apr 21 449-459

Gender differences in outcomes of patients with cystic fibrosis

Harness-Brumley CL, Elliott AC, Rosenbluth DB, Raghavan D, Jain R 2014 Dec 23 1012-1020

Effects of puberty on cystic fibrosis related pulmonary exacerbations in women versus men

Sutton S, Rosenbluth D, Raghavan D, Zheng J, Jain R 2014 Jan 49 28-35

Sex hormone-dependent regulation of cilia beat frequency in airway epithelium

Jain R, Ray JM, Pan JH, Brody SL 2012 Apr 46 446-453

Sensory functions of motile cilia and implication for bronchiectasis

Jain R, Javidan-Nejad C, Alexander-Brett J, Horani A, Cabellon MC, Walter MJ, Brody SL 2012 Jan 4 S 1088-1098

Temporal relationship between primary and motile ciliogenesis in airway epithelial cells

Jain R, Pan J, Driscoll JA, Wisner JW, Huang T, Gunsten SP, You Y, Brody SL 2010 Dec 43 731-739

Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome

Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, Huang HJ, Mohanakumar T, Patterson GA, Walter MJ 2010 May 29 531-537

Severe hypoglycemia associated with use of trimethoprim/sulfamethoxazole in a patient with chronic renal insufficiency

Rosini JM, Martinez E, Jain R 2008 Apr 42 593-594

Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-β1

Jain R, Shaul PW, Borok Z, Willis BC 2007 Jul 37 38-47

Eosinophilic lung disease associated with non-Hodgkin lymphoma: A case report and review of the literature

Jain R, Katz JN, Amirkhan RH, Glazer C 2007 Jan 14 13-16

Bronchorrhoea complicating inflammatory bowel disease

Jain R, Scheurich D, Lindberg GM, Girod CE 2006 Nov 61 1014

Pharmacological therapy for acute respiratory distress syndrome

Jain R, DalNogare A 2006 Feb 81 205-212